World's Best Scientists 2026 revealed!
Nancy Agmon-Levin

Nancy Agmon-Levin

D-Index & Metrics

Immunology

D-Index
68
Citations
17702
World Ranking
2580
National Ranking
16

Nancy Agmon-Levin publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Nancy Agmon-Levin sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 235 publications — 46th percentile

46% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Nancy Agmon-Levin D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Nancy Agmon-Levin sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 68 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Nancy Agmon-Levin is affiliated with Sheba Medical Center in Israel and has a significant publication record in the field of medicine, with a focus on rheumatology, immunology, hematology, genetics, and infectious diseases. Their research encompasses a variety of topics, including systemic lupus erythematosus, platelet disorders and treatments, urticaria and related conditions, coagulation, bradykinin, polyphosphates, angioedema, SARS-CoV-2 and COVID-19 research, drug-induced adverse reactions, and food allergy and anaphylaxis research.

Their recent papers include:

  • 2023 ACR/EULAR antiphospholipid syndrome classification criteria, 2023, Annals of the Rheumatic Diseases
  • Minor Clinical Impact of COVID-19 Pandemic on Patients With Primary Immunodeficiency in Israel, 2021, Frontiers in Immunology
  • Prevalence of Allergic Reactions After Pfizer-BioNTech COVID-19 Vaccination Among Adults With High Allergy Risk, 2021, JAMA Network Open
  • Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases, 2021, RMD Open
  • Efficacy of omalizumab treatment for pediatric chronic spontaneous urticaria: A multi-center retrospective case series, 2020, Pediatric Dermatology

Frequent coauthors in their work include:

  • Soad Haj Yahia
  • Ramit Maoz-Segal
  • Stanley Niznik
  • Ronen Shavit
  • Daphna Paran

Their publications have been predominantly featured in venues such as:

  • Annals of the Rheumatic Diseases
  • Frontiers in Immunology
  • World Allergy Organization Journal
  • Lupus
  • RMD Open

In addition to journal articles, Nancy Agmon-Levin has contributed to book publications. Notably, they authored a book titled New Biomarkers for the Diagnosis and Treatment of Systemic Lupus Erythematosus, published in 2022 by Frontiers Media.

Best Publications

  • 'ASIA' - autoimmune/inflammatory syndrome induced by adjuvants.

    Yehuda Shoenfeld;Nancy Agmon-Levin

  • EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome

    L. Andreoli;G. K. Bertsias;N. Agmon-Levin;S. Brown

  • 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

    Victoria Furer;Victoria Furer;Christien Rondaan;Marloes W. Heijstek;Nancy Agmon-Levin;Nancy Agmon-Levin

  • EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

    S van Assen;N Agmon-Levin;O Elkayam;R Cervera

  • International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies

    Nancy Agmon-Levin;Nancy Agmon-Levin;Jan Damoiseaux;Cornelis Kallenberg;Ulrich Sack

  • Infections and autoimmunity--friends or foes?

    Shaye Kivity;Nancy Agmon-Levin;Miri Blank;Yehuda Shoenfeld;Yehuda Shoenfeld

  • Vitamin D and autoimmune thyroid diseases

    Shaye Kivity;Nancy Agmon-Levin;Michael Zisappl;Yinon Shapira

  • Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D?

    H. Amital;Z. Szekanecz;G. Szücs;K. Dankó

  • Adjuvants and autoimmunity.

    E. Israeli;N. Agmon-Levin;M. Blank;Y. Shoenfeld

  • Defining and analyzing geoepidemiology and human autoimmunity.

    Yinon Shapira;Nancy Agmon-Levin;Yehuda Shoenfeld;Yehuda Shoenfeld

  • Vaccines and Autoimmunity

    Nancy Agmon-Levin;Ziv Paz;Eitan Israeli;Yehuda Shoenfeld

  • Vitamin D in systemic and organ-specific autoimmune diseases.

    Nancy Agmon-Levin;Emanuel Theodor;Ramit Maoz Segal;Yehuda Shoenfeld;Yehuda Shoenfeld

  • Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) 2013: Unveiling the pathogenic, clinical and diagnostic aspects.

    Carlo Perricone;Serena Colafrancesco;Serena Colafrancesco;Roei D. Mazor;Alessandra Soriano;Alessandra Soriano

  • Geoepidemiology of autoimmune rheumatic diseases

    Yinon Shapira;Nancy Agmon-Levin;Yehuda Shoenfeld

  • Thymoma and autoimmunity.

    Shahar Shelly;Nancy Agmon-Levin;Arie Altman;Yehuda Shoenfeld;Yehuda Shoenfeld

  • 14th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome.

    Ricard Cervera;Ignasi Rodríguez-Pintó;Serena Colafrancesco;Fabrizio Conti

  • Systemic lupus erythematosus one disease or many

    N. Agmon-Levin;M. Mosca;M. Petri;Y. Shoenfeld;Y. Shoenfeld

  • Neuropsychiatric lupus: a mosaic of clinical presentations

    Shaye Kivity;Shaye Kivity;Nancy Agmon-Levin;Nancy Agmon-Levin;Gisele Zandman-Goddard;Gisele Zandman-Goddard;Joab Chapman;Joab Chapman

  • Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials.

    Megan E. B. Clowse;Daniel J. Wallace;Richard A. Furie;Michelle A. Petri

  • Fibromyalgia and cytokines.

    Ignasi Rodriguez-Pintó;Nancy Agmon-Levin;Nancy Agmon-Levin;Amital Howard;Yehuda Shoenfeld;Yehuda Shoenfeld

  • 14th International Congress on Antiphospholipid Antibodies Task Force report on obstetric antiphospholipid syndrome.

    Guilherme R. de Jesus;Nancy Agmon-Levin;Carlos A. Andrade;Laura Andreoli

  • Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: A systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases

    S. van Assen;O. Elkayam;N. Agmon-Levin;R. Cervera

Frequent Co-Authors

Yehuda Shoenfeld
Yehuda Shoenfeld Sheba Medical Center
Howard Amital
Howard Amital Sheba Medical Center
Carlo Perricone
Carlo Perricone University of Perugia
Miri Blank
Miri Blank Tel Aviv University
Gisele Zandman-Goddard
Gisele Zandman-Goddard Wolfson Medical Center
Boris Gilburd
Boris Gilburd Sheba Medical Center
Juan-Manuel Anaya
Juan-Manuel Anaya Universidad del Rosario
Angela Tincani
Angela Tincani University of Brescia
Guido Valesini
Guido Valesini Sapienza University of Rome
Pnina Langevitz
Pnina Langevitz Tel Aviv University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Immunology in the USA often opens doors to diverse healthcare roles, including those in nursing and advanced practice. For professionals aiming to enhance their qualifications, exploring doctor of nursing practice salary trends by state can help make informed decisions about where to study or work.

Nurses looking to specialize further might consider transitioning from a Family Nurse Practitioner (FNP) to an Acute Care Nurse Practitioner (ACNP), a pathway detailed in resources like fnp to acnp.

Those interested in fast-tracking their careers can benefit from accelerated np programs, which offer flexible schedules and condensed curriculums tailored for busy students or working professionals.

Additionally, many institutions now provide online nursing programs for non nurses, making it easier for individuals without a nursing background to enter this vital field. These pathways enhance career versatility and growth opportunities in immunology-related healthcare.

Best Scientists Citing Nancy Agmon-Levin

Trending Scientists

Recently Published Articles